NovoRapid (Insulin Aspart) NovoRapid sales in 2022: $2.259 billion Company/Developer: Novo Nordisk Date of first FDA approval: June 7, 2000 Indications NovoRapid is FDA-approved for: Type 1 and 2 diabetes Price of NovoRapid: NovoLog FlexPen (pre-filled NovoRapid pen) injectable solution (100 units/mL) is around $157 for 15 mL Why it did so well: Novo Nordisk joined other insulin makers, led by Eli Lilly, last year and cut the price of its insulin analog NovoRapid by 25 percent, bringing its cost down to $72.34 from $289.36
GLP-1 mimetic drugs can help with weight control and metabolic fitness, thus facilitating long-term body transformation in conjunction with lifestyle interventions
Possibly better effects on fat metabolism (though research is ongoing) thanks to GIPs involvement
A one- to twofold enlargement, often accompanied by other nuclear irregularities (irregular contours, nucleoli, hyperchromatism), is judged as moderate
It supports nerve function and promotes better pain regulation